Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana

Joseph C Forbi1, Jennifer E Layden2,3, Richard O Phillips4,5

  • 1Molecular Epidemiology and Bioinformatics Laboratory, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Plos One
|December 20, 2015
PubMed

Insights

Hepatitis C Virus (HCV) infection in Ghana shows high genetic diversity, particularly for genotype 2 (HCV-2), with evidence of rapid strain switching and transmission. This suggests a long epidemic history of HCV-2 in the region.

Area of Science:

  • Virology
  • Epidemiology
  • Genetics

Background:

  • Hepatitis C Virus (HCV) causes significant liver disease globally, with high prevalence in sub-Saharan Africa.
  • West Africa is a known origin for two HCV genotypes, but regional genetic diversity remains poorly understood.
  • Understanding HCV genetic composition is crucial for public health interventions in endemic areas.

Purpose of the Study:

  • To genetically characterize Hepatitis C Virus (HCV) strains circulating in blood donors in Kumasi, Ghana.
  • To investigate the genetic diversity, population structure, and evolutionary history of HCV in the region.
  • To assess the implications of HCV genetic diversity for transmission dynamics.

Main Methods:

  • Conventional and next-generation sequencing (NGS) were used to analyze 65 HCV strains.
  • Phylogenetic analysis was performed on consensus sequences from the 5'-untranslated region, HVR1, and NS5B gene.
  • Bayesian analysis was employed to estimate the evolutionary history of HCV strains.

Main Results:

  • HCV genotypes 1 (15%) and 2 (85%) were identified, with HCV-2 being predominant.
  • Significant genetic heterogeneity of HCV-2 was observed in Ghana, with intermixed sequences in phylogenetic analysis.
  • Intra-host sequencing revealed multiple infections, strain co-infections, and evidence of recent HCV transmission among donors.
  • Bayesian analysis indicated HCV-2 strains have been expanding in Ghana since the 16th century.

Conclusions:

  • The HCV population in Kumasi, Ghana, is genetically diverse, dominated by HCV-2.
  • Evidence of co-infections, transmission, and rapid strain switching suggests frequent HCV exposure and a long epidemic history.
  • Findings highlight the need for targeted public health strategies considering the specific HCV genetic landscape in Ghana.